Ryosuke Nemoto

1.2k total citations
90 papers, 883 citations indexed

About

Ryosuke Nemoto is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ryosuke Nemoto has authored 90 papers receiving a total of 883 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Surgery, 23 papers in Pulmonary and Respiratory Medicine and 23 papers in Oncology. Recurrent topics in Ryosuke Nemoto's work include Bladder and Urothelial Cancer Treatments (23 papers), Bone health and treatments (12 papers) and Radiopharmaceutical Chemistry and Applications (10 papers). Ryosuke Nemoto is often cited by papers focused on Bladder and Urothelial Cancer Treatments (23 papers), Bone health and treatments (12 papers) and Radiopharmaceutical Chemistry and Applications (10 papers). Ryosuke Nemoto collaborates with scholars based in Japan, United States and Pakistan. Ryosuke Nemoto's co-authors include Tetsuro Kato, Masaoki Harada, Kenkichi Koiso, Hisashi Mori, Katsunori Uchida, Kazunori Hattori, Mutsumasa Takahashi, Toru Shimazui, Kiyoshi Ishikawa and Isao Nakamura and has published in prestigious journals such as Cancer, The Journal of Urology and British Journal of Cancer.

In The Last Decade

Ryosuke Nemoto

85 papers receiving 835 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryosuke Nemoto Japan 17 294 293 239 188 130 90 883
P L Choyke United States 11 265 0.9× 155 0.5× 260 1.1× 112 0.6× 84 0.6× 19 808
S Biran Israel 16 131 0.4× 264 0.9× 273 1.1× 171 0.9× 76 0.6× 84 977
E. Edmund Kim United States 14 204 0.7× 233 0.8× 136 0.6× 86 0.5× 284 2.2× 29 639
Masahiko Harada Japan 16 267 0.9× 206 0.7× 265 1.1× 176 0.9× 67 0.5× 85 962
Roberto Díaz United States 19 321 1.1× 353 1.2× 292 1.2× 217 1.2× 110 0.8× 57 1.0k
C Sakakura Japan 17 308 1.0× 267 0.9× 363 1.5× 354 1.9× 38 0.3× 28 983
Tal Grenader Israel 18 224 0.8× 491 1.7× 198 0.8× 175 0.9× 40 0.3× 64 1.0k
Yasuhisa Koyanagi Japan 18 247 0.8× 470 1.6× 395 1.7× 313 1.7× 39 0.3× 97 1.2k
Yasuto Onoyama Japan 15 186 0.6× 103 0.4× 178 0.7× 92 0.5× 143 1.1× 57 790
Tatsuya Manabe Japan 18 157 0.5× 544 1.9× 318 1.3× 245 1.3× 98 0.8× 63 1.0k

Countries citing papers authored by Ryosuke Nemoto

Since Specialization
Citations

This map shows the geographic impact of Ryosuke Nemoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryosuke Nemoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryosuke Nemoto more than expected).

Fields of papers citing papers by Ryosuke Nemoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryosuke Nemoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryosuke Nemoto. The network helps show where Ryosuke Nemoto may publish in the future.

Co-authorship network of co-authors of Ryosuke Nemoto

This figure shows the co-authorship network connecting the top 25 collaborators of Ryosuke Nemoto. A scholar is included among the top collaborators of Ryosuke Nemoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryosuke Nemoto. Ryosuke Nemoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saida, Tsukasa, Miki Yoshida, Ryosuke Nemoto, et al.. (2025). Multi–b-value diffusion-weighted imaging–derived parameters for differentiating high-grade serous ovarian carcinoma from other epithelial ovarian cancers. Japanese Journal of Radiology. 43(10). 1678–1687.
2.
Ichiyama, Susumu, Ryosuke Nemoto, Hiroki Tanabe, & Tatsuya Haga. (2014). Interaction of the muscarinic acetylcholine receptor M2 subtype with G protein G i/o isotypes and G   subunits as studied with the maltose-binding protein-M2-G i/o fusion proteins expressed in Escherichia coli. The Journal of Biochemistry. 156(5). 259–272. 1 indexed citations
3.
Watanabe, Takeshi, et al.. (2011). Interstitial pneumonitis induced by bicalutamide given for prostate cancer. International Journal of Clinical Oncology. 16(6). 763–765. 9 indexed citations
4.
Nemoto, Ryosuke, et al.. (1997). Serum pyridinoline crosslinks as markers of tumour‐induced bone resorption. British Journal of Urology. 80(2). 274–280. 18 indexed citations
5.
Nemoto, Ryosuke, Isao Nakamura, Y Oshika, & Masato Nakamura. (1996). Transitional cell carcinoma of the bladder producing granulocyte colony‐stimulating factor: a case report of molecular diagnosis. British Journal of Urology. 78(4). 653–654. 5 indexed citations
6.
Nemoto, Ryosuke, Isao Nakamura, Kazushige Uchida, & Masaoki Harada. (1995). Numerical chromosome aberrations in bladder cancer detected by in situ hybridization. British Journal of Urology. 75(4). 470–476. 9 indexed citations
7.
Hattori, Kazunori, et al.. (1995). Proliferating cell nuclear antigen cyclin in human transitional cell carcinoma. British Journal of Urology. 75(2). 162–166. 13 indexed citations
8.
Nemoto, Ryosuke, et al.. (1995). Diagnosis and treatment of renovascular hypertension in a patient with a functional solitary kidney. British Journal of Urology. 76(3). 410–410. 1 indexed citations
10.
Harada, Masaoki, Ryosuke Nemoto, Katsunori Uchida, et al.. (1993). HISTOPATHOLOGICAL COMPARISON OF PROSTATIC ADENOCARCINOMA IN JAPAN AND THE UNITED STATES. The Japanese Journal of Urology. 84(6). 1110–1118. 9 indexed citations
11.
Harada, Masaoki, Akio Shimizu, Yoshiyasu Nakamura, & Ryosuke Nemoto. (1992). Role of the Vertebral Venous System in Metastatic Spread of Cancer Cells to the Bone. Advances in experimental medicine and biology. 324. 83–92. 30 indexed citations
12.
Nemoto, Ryosuke, et al.. (1992). Response of MBT-2 bladder carcinoma-induced osteolysis to various agents. Cancer. 69(9). 2316–2321. 6 indexed citations
13.
Koiso, Kenkichi, Ryosuke Nemoto, Kohji Uchida, et al.. (1991). Evaluation of the Invasive Potential of Superficial Bladder Cancer by Adenosine Triphosphate Measurement. Urologia Internationalis. 46(2). 145–148. 6 indexed citations
14.
Nemoto, Ryosuke, et al.. (1991). Inhibition by a new bisphosphonate (AHBuBP) of bone resorption induced by the MBT-2 tumor of mice. Cancer. 67(3). 643–648. 10 indexed citations
15.
Nemoto, Ryosuke, et al.. (1990). Estimation of Growth Fraction in situ in Human Bladder Cancer with Bromodeoxyuridine Labelling. British Journal of Urology. 65(1). 27–31. 10 indexed citations
16.
Shimazui, Toru, Ryosuke Nemoto, Kenkichi Koiso, & Yasuo Uchiyama. (1989). Evaluation of human bladder tumors by ultrastructural morphometric techniques. Virchows Archiv B Cell Pathology Including Molecular Pathology. 57(1). 195–202. 2 indexed citations
17.
Nemoto, Ryosuke, et al.. (1988). Tumor-bone interaction induced by transplantable human tumors in nude mice. Cancer. 62(7). 1310–1316. 8 indexed citations
18.
Ohtani, Mikinobu, et al.. (1987). Intra-arterial chemotherapy for bladder cancer. Cancer Chemotherapy and Pharmacology. 20(S1). S6–9. 3 indexed citations
19.
Nemoto, Ryosuke, et al.. (1987). A model of localized osteolysis induced by the MBT-2 tumor in mice and its responsiveness to etidronate disodium. Journal of Cancer Research and Clinical Oncology. 113(6). 539–543. 23 indexed citations
20.
Nemoto, Ryosuke, et al.. (1985). Incidental carcinoma of the prostate in Japan: histological characteristics and tumor size.. PubMed. 3(4). 215–20. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026